[Wall Street Journal] Atomwise Inc., which uses artificial intelligence to help academic and commercial scientists discover new medicines, has raised $123 million to expand and build its own pipeline of experimental drugs.
Small molecule found to block CD163 surface receptor, which PRRS virus needs to infect pig cells and cause disease.
University of Connecticut (UConn) researchers have identified a compound that can successfully block the Porcine Reproductive and Respiratory Syndrome (PRRS) virus.
The quantity of data about medicines, diseases, and biology is growing. So too, are the number of companies that employ artificial intelligence in drug discovery. Most of the low-hanging fruit in drug research has already been picked, and the industry is clamoring to make sense of the new data, according to Jeffrey Lu, CEO and […]
Artificial intelligence (AI) is amplifying the pace of drug development, allowing developers to attack otherwise intractable problems and achieve results in weeks. Previously, results may have been impossible within any time frame.
University of Connecticut professor of molecular and cell biology James Cole is working on identifying new therapeutics for COVID-19. Through a collaboration with Atomwise, Cole is one of the 15 researchers looking at different coronavirus protein targets for COVID-19 treatment.